Empowering Women with ADHD
Busy Philipps, a multifaceted actress and author, is taking a remarkable step toward empowering women with attention-deficit/hyperactivity disorder (ADHD). In collaboration with Supernus Pharmaceuticals, Busy has launched a unique campaign designed to raise awareness and promote understanding of ADHD among women. The campaign emphasizes her own experiences and struggles with ADHD, aiming to inspire others who share the same diagnosis.
The Challenges Faced by Women with ADHD
ADHD has traditionally been viewed through the lens of hyperactive behaviors, often associated with male patients. This has led to a greater number of boys being diagnosed compared to girls. In fact, girls are less likely to be recognized as having ADHD due to a different presentation of symptoms. Busy highlights that many women experience predominantly inattentive symptoms, such as difficulties in maintaining focus, organization challenges, and feeling overwhelmed. These symptoms often go unnoticed and are mistakenly attributed to personality traits.
Busy's Personal Journey
In her role as 'Ms. Represented', Busy Philipps opens up about her own journey with ADHD and how she addressed her symptoms with the help of Qelbree (viloxazine extended-release capsules). This innovative, non-stimulant treatment is approved for individuals aged 6 years and older and provides a different approach to managing ADHD symptoms. Busy emphasizes the importance of recognizing the often-misunderstood experiences of women facing ADHD, stating, "Many women feel misrepresented within the ADHD narrative, and I believe it’s crucial for them to realize their symptoms are valid. Seeking proper diagnosis and treatment can be life-changing. For me, understanding that my struggles correlated with ADHD was vital to getting the help I needed."
Breaking the Stigma
The stark difference in diagnosis rates between males and females can create significant hurdles for women, leading to missed opportunities for early intervention. Reports indicate that many women are not diagnosed until late adolescence or even adulthood, resulting in prolonged challenges as they navigate life without appropriate support. With campaigns like the one initiated by Busy and Supernus, awareness is growing, prompting more women to pursue diagnosis and appropriate treatment options.
Supernus Pharmaceuticals' Commitment
Jack Khattar, President and CEO of Supernus Pharmaceuticals, articulated the company's dedication to recognizing the different experiences of women with ADHD. He stated, "At Supernus, addressing the unique symptoms experienced by individuals with ADHD is our top priority. With Busy’s authentic narrative, we are eager to elevate conversations around this important topic." The 'Ms. Represented' campaign honors these unique experiences and promotes actionable discussions that can lead to better understanding and support.
Understanding Qelbree
Qelbree represents a breakthrough in ADHD treatment as the first non-stimulant medication approved for adults in the last two decades. It provides a daily treatment option that comes with fewer concerns regarding misuse or dependency. As Busy Philipps champions awareness around ADHD, Qelbree stands as a viable option for patients looking for effective symptomatic relief without the attributes of traditional stimulant medications.
Seek Guidance and Support
For anyone considering ADHD treatment options, it is essential to consult with healthcare providers to explore what medications may be most suitable. Qelbree offers an opportunity for individuals aged six and older to manage their attention deficit symptoms effectively. Moreover, it is crucial for patients to communicate openly with their doctors about their experiences and any other medications they are currently taking.
Frequently Asked Questions
What is the primary goal of Busy Philipps' campaign?
The campaign aims to empower women with ADHD by raising awareness about the unique challenges they face and encouraging them to seek diagnosis and treatment.
How does ADHD present differently in women?
Women often experience inattentive symptoms, such as difficulty focusing and disorganization, which can be overlooked compared to the hyperactive symptoms more common in men.
What is Qelbree?
Qelbree is a non-stimulant medication used to treat ADHD in individuals aged six years and older, offering an alternative for effective symptom management without the risk of abuse typically associated with stimulant medications.
Why is there a disparity in ADHD diagnoses between genders?
Boys are diagnosed with ADHD at twice the rate of girls, often due to different symptom presentations in females that are less recognized in clinical settings.
How can women find support for ADHD?
Women are encouraged to discuss their symptoms with healthcare providers and consider joining support groups focused on ADHD to connect with others who share similar experiences.
